Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S279000, C544S244000, C544S117000, C514S264110, C514S234200

Reexamination Certificate

active

07053070

ABSTRACT:
Disclosed are compounds of the formulawherein R2, R5, R6, R7, and R8are as defined herein. These compounds and their pharmaceutical compositions are useful for treating cell proliferative disorders, such as cancer and restenosis. These compounds are potent inhibitors of cdks and growth factor-mediated kinases.

REFERENCES:
patent: 5620981 (1997-04-01), Blankley et al.
patent: 5733913 (1998-03-01), Blankley et al.
patent: 5952342 (1999-09-01), Blankley et al.
patent: 2003/0149001 (2003-08-01), Barvian et al.
patent: 2003/0171584 (2003-09-01), Chen et al.
patent: 2004/0224958 (2004-11-01), Booth et al.
patent: WO 99/61444 (1999-12-01), None
patent: WO 200170741 (2001-09-01), None
J. M. Hamby, et al., “Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors”, J. Med. Chem., 1997, pp 2296-2303, vol. 40, No. 15.
S. Trumpp-Kallmeyer, et al., “Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors”, J. Med. Chem., 1998, pp1752-1763, vol. 41, No. 11.
C. J. Connolly, et al., “Discovery and Structure-Activity Studies of a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors”, Bioorg. Med. Chem. Letters, 1997, pp 2415-2420, vol. 7, No. 18.
M. R. Barvian, et al., “Preparation of N,N′-Bis9aryl)guanidines from Electron Deficient Amines Via Masked Carbodiimides”, Tetrahedron Letters, 1997, pp 6799-6802, vol. 38, No. 39.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3652477

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.